Research indicates that patients can lose an average of 14.9% of their body mass over 68 weeks when following a structured plan, underscoring the importance of ongoing support
We currently provide Wegovy, Mounjaro, and Nevolat, which are injectable pre-filled pens
Ozempic, still only offered as a brand-name drug, can come with higher out-of-pocket costs
GHRH analogs (like CJC-1295) act on the GHRH receptor to stimulate GH synthesis/release
Using intuitive eating to guide portions The balanced plate model works effectively with GLP-1 medications: fill 50% with non-starchy vegetables, 25% with lean protein, and 25% with quality carbohydrates
These may be prioritised before or alongside GLP-1 receptor agonists in appropriate patients